Site icon OncologyTube

PAPMET trial (SWOG 1500) in Papillary Renal Cell Cancer: Rationale and Current Status

Primo N. Lara, Jr., MD, Professor of Medicine, University of California Davis School of Medicine, Acting Director, UC Davis Comprehensive Cancer Center presents PAPMET trial (SWOG 1500) in Papillary Renal Cell Cancer: Rationale and Current Status at the 2016 annual International Kidney Cancer Symposium.

Exit mobile version